Hair Relaxer Chemical Hair Straightener Lawsuit, Are You Eligible to Join?

The chemical hair straightener lawsuit is a mass tort litigation where women diagnosed with uterine cancer, endometrial cancer, ovarian cancer, or related conditions after long-term use of chemical hair relaxers may have legal standing to join. As of February 2026, 11,195 lawsuits are pending in MDL-3060 before Judge Mary M. Rowland in the U.S. District Court for the Northern District of Illinois, making it the fifth-largest active multidistrict litigation in the federal court system. Defendants include some of the most recognizable names in the hair care industry — and no settlement has been reached yet.

Quick Facts: In re Hair Relaxer Marketing, Sales Practices and Products Liability Litigation

Field	Detail
Case Name	In re: Hair Relaxer Marketing, Sales Practices and Products Liability Litigation
MDL Number	MDL 3060 / Master Docket No. 23 CV 0818
Settlement Status	Litigation Phase — No Settlement Reached
Filing Date (MDL Established)	February 6, 2023
Current Court Stage	Expert discovery phase; Daubert motions filed April 1, 2026
Who Qualifies	Women diagnosed with uterine, endometrial, or ovarian cancer, endometriosis, or uterine fibroids after long-term chemical hair relaxer use
Claim Deadline	TBD — No settlement reached; no claim form exists yet
Payout Per Person	TBD — No settlement confirmed; bellwether trials expected 2027
Key Defendants	L’Oréal USA, SoftSheen-Carson, Revlon, Strength of Nature, and others
Presiding Judge	Judge Mary M. Rowland, Northern District of Illinois
Lead Plaintiffs’ Firms	DiCello Levitt, Douglas & London, Motley Rice, Ben Crump Law
Last Updated	April 23, 2026

Current Status & What Happens Next

• General causation expert discovery for the 32 bellwether cases closed March 2, 2026, and Daubert motions — formal legal challenges to each side’s scientific experts — were due April 1, 2026. The outcome of these motions will determine which scientific evidence reaches a jury.
• Bellwether trials in the MDL will not start until 2027. State court claims may move faster and could push earlier settlement talks than a 2027 trial date would suggest.
• Ellen Reisman was appointed as Special Master in May 2025 to help facilitate and coordinate settlement negotiations between plaintiffs and defendants — a signal that both sides are at least beginning informal discussions.

What Is the Chemical Hair Straightener Lawsuit About? In re: Hair Relaxer Marketing, Sales Practices and Products Liability Litigation, MDL No. 3060

For decades, manufacturers sold chemical hair relaxers and straighteners to millions of women — products containing formaldehyde, parabens, phthalates, bisphenol A (BPA), and other endocrine-disrupting chemicals (EDCs). These companies aggressively marketed their products to Black women and girls, sometimes promoting use from as young as age five.

In October 2022, a landmark study from the National Institutes of Health (NIH) — the Sister Study — confirmed what many suspected: women who used chemical hair straightening products more than four times per year had 2.55 times the risk of uterine cancer compared to women who did not use them. The study followed 33,497 women for approximately 11 years.

The MDL is a landmark case against some of the nation’s largest hair product manufacturers, including L’Oréal, SoftSheen-Carson LLC, Revlon, Inc., and others, for manufacturing and marketing toxic chemical hair relaxers to Black and Brown women, which plaintiffs allege caused these women to develop uterine, endometrial, and ovarian cancer. The core legal theory is products liability — specifically that manufacturers knew or should have known about these cancer risks and failed to warn consumers.

The primary harmful chemical at the center of the litigation is Di-2-ethylhexyl phthalate (DEHP), an endocrine-disrupting chemical used in hair relaxer formulas to help the product adhere to the scalp. DEHP has been classified by the International Agency for Research on Cancer (IARC) as potentially carcinogenic to humans. Formaldehyde, another common ingredient in chemical hair straighteners — even in products labeled as “formaldehyde-free” — has been classified as a known human carcinogen by both the U.S. National Toxicology Program (NTP) and the WHO’s IARC.

Approximately 60% of the participants who used chemical straighteners in the NIH study identified as Black women — a fact central to the plaintiffs’ argument that these communities faced targeted marketing while being denied adequate safety warnings. 

Who Is Eligible for the Chemical Hair Straightener Lawsuit?

The proposed class covers all people who purchased, acquired, or used chemical hair relaxer or straightener products and were diagnosed with a qualifying condition as a result.

• You may qualify if you used chemical hair relaxers or straighteners — including products like Dark & Lovely, Just for Me, Optimum, or Revlon Realistic — on a regular basis for an extended period of time.
• You may qualify if you were diagnosed with uterine cancer (endometrial cancer) after long-term use of these products.
• You may qualify if you were diagnosed with ovarian cancer, endometrial cancer, endometriosis, or uterine fibroids that your doctor connects to chemical exposure.
• You may qualify if you began using hair relaxers as a child or teenager, as children exposed to the carcinogens in hair relaxers are at an even greater risk of eventually developing uterine, endometrial, or ovarian cancer at some point during their lifetime.
• You may qualify if you are a hair stylist or cosmetologist who experienced occupational exposure — hair stylists and cosmetologists are emerging as some of the strongest plaintiffs due to daily exposure and significant financial losses.
• You may qualify if you used these products in any U.S. state — the MDL accepts direct filings from all 50 states.

Note: The MDL currently focuses primarily on uterine, endometrial, and ovarian cancer. A related consumer class action is also moving forward that seeks refunds and medical monitoring for individuals who purchased chemical hair straighteners, arguing that manufacturers misrepresented the safety of their products. Consult an attorney to determine which path fits your specific injury.

Potential Recovery & Legal Theory

No individual payout amounts are confirmed. What plaintiffs are seeking breaks into three categories.

First, compensatory damages for medical expenses, lost income, pain and suffering, and ongoing treatment costs related to a cancer diagnosis. Some lawyers predict that a settlement for the hair straightener lawsuits could range from $100,000 to $1.75 million, mainly because of claims related to cancer. These estimates are based on past cases involving similar claims about other products — they are not guaranteed figures and depend heavily on the individual case and bellwether trial outcomes.

Second, punitive damages for alleged concealment. Plaintiffs argue that defendants knew their products contained dangerous levels of DEHP, formaldehyde, and parabens but chose profits over consumer safety warnings. Internal FDA emails obtained via FOIA revealed that scientists deemed hair straighteners with formaldehyde unsafe — documents plaintiffs say support a concealment theory.

Third, the consumer class action running parallel to the MDL seeks product refunds and medical monitoring — meaning defendants could be forced to fund long-term cancer screening for women who used these products. Right now, the litigation features pretrial discovery battles, growing scientific evidence, and a rising number of claims pointing to the connection between chemical hair straighteners and hormone-related cancers.

How to Join the Chemical Hair Straightener Lawsuit

No claim form exists yet. The MDL is in its expert discovery phase. Here is what eligible women should do right now:

Step 1 — Document your product history. Write down every hair relaxer or chemical straightener brand you used, approximate years of use, and frequency. Receipts are helpful but not required — brand recognition is enough at this early stage.

Step 2 — Gather your medical records. Obtain your diagnosis paperwork, treatment history, and any pathology reports confirming uterine, ovarian, or endometrial cancer, endometriosis, or fibroids.

Step 3 — Contact one of the lead plaintiffs’ firms — DiCello Levitt, Motley Rice, Douglas & London, or Ben Crump Law — for a free case evaluation. These firms represent the class and do not charge upfront fees.

Step 4 — If filing a new individual case, it must be filed separately in the Northern District of Illinois, noting the connection to MDL 3060 and master docket number 23 CV 0818 on the civil cover sheet. An attorney will handle this on your behalf.

Step 5 — If you received a court notice about this MDL by mail, save it. Review it carefully and respond within any stated deadlines — missing procedural deadlines can affect your standing in the litigation.

Step 6 — Monitor the PACER docket at pacer.gov for case management orders, bellwether trial scheduling, and any future settlement notices. Your attorney should also provide updates automatically.

Most plaintiffs who join the MDL are automatically included in the class once certified. You generally do not need to take action beyond retaining counsel.

Case Timeline

Event	Date
NIH Sister Study Published — 2.55× Uterine Cancer Risk Finding	October 17, 2022
MDL 3060 Established by JPML	February 6, 2023
Judge Mary Rowland Assigned to MDL	February 2023
MDL Reaches 10,000+ Pending Cases	October 2025
Science Day Hearing — Scientific Evidence Presented to Judge	January 8, 2026
General Causation Expert Discovery Closes (32 Bellwether Cases)	March 2, 2026
Daubert Motions Filed (Challenges to Scientific Experts)	April 1, 2026
MDL Active Case Count	~15,000+ (April 2026)
Bellwether Trials Expected	2027 (TBD — pending Daubert rulings)
Potential Global Settlement Discussions	TBD — Special Master appointed May 2025

Frequently Asked Questions

Do I need a lawyer to join the chemical hair straightener lawsuit? 

Yes — this is not a standard claim form process. To join MDL 3060 in the Northern District of Illinois, you need legal representation. The lead firms — including DiCello Levitt, Motley Rice, and Ben Crump Law — offer free case evaluations and work on contingency, meaning no upfront cost to you.

Is the hair relaxer MDL legitimate? 

Yes. MDL 3060 was centralized in the Northern District of Illinois and involves thousands of women who allege long-term exposure to hair relaxer products from L’Oréal, SoftSheen-Carson, and others led to hormone-related cancers. It is an active federal court proceeding overseen by a sitting federal judge, and it is one of the largest active mass torts in the country.

When will I receive a payment? 

No payment timeline is confirmed. Bellwether trials in the MDL will not start until 2027, and state court claims may move faster. Most mass tort litigations of this size resolve 4–7 years after the MDL is formed — meaning realistic settlement distributions are likely no earlier than 2027 or 2028. Monitor court filings via PACER for updates.

What if I missed the deadline to file? 

No universal filing deadline currently exists because the litigation has not settled. Judge Rowland has created a pathway for some dismissed lawsuits to rejoin the litigation through Case Management Order 16, which allowed people with dismissed cases to submit new plaintiff fact sheets — showing that the court has been flexible on procedural issues. Contact a plaintiff’s firm immediately if you believe you have a qualifying injury.

Will a settlement payment affect my taxes? 

Possibly. The IRS generally treats lawsuit settlements as taxable income unless the payment specifically compensates for physical injury. Cancer-related damages may receive different tax treatment than property or refund claims. Consult a tax professional once any recovery is confirmed — no payment is imminent at this stage.

What brands of hair relaxer are named in the lawsuit?

 The complaint targets well-known defendants including L’Oréal, Revlon, SoftSheen-Carson, and Strength of Nature, accusing them of manufacturing and marketing products such as Dark and Lovely, Just for Me, and Revlon Realistic without adequate warnings about their risks. Other brands and defendants are also included in the MDL.

What cancers qualify for the hair relaxer lawsuit?

 Qualifying conditions with the strongest evidence include uterine cancer (2.55× risk in the NIH study), ovarian cancer, endometriosis, and uterine fibroids. Breast cancer is also being evaluated — consult a plaintiff’s attorney about your specific diagnosis. The MDL’s primary focus is on hormone-driven, reproductive cancers linked to endocrine-disrupting chemical exposure.

What is a “bellwether trial” and how does it affect my case? 

A bellwether trial is a test case — a small set of representative lawsuits tried before a jury to see how the evidence plays out. Bellwether trials in MDL 3060 are designed to test claims that chemical hair relaxers cause uterine, endometrial, and ovarian cancers. Results from these initial trials could shape future settlement negotiations and litigation outcomes. If plaintiffs win bellwether trials, defendants face strong pressure to settle the remaining thousands of cases.

Sources & References

• U.S. District Court, Northern District of Illinois — MDL 3060, Master Docket No. 23 CV 0818: https://pacer.gov
• Verus LLC — MDL 3060 Key Updates and Deadlines (Primary court schedule source): https://verusllc.com/articles/case-management/judge-appoints-mdl-3060-leadership-team-for-hair-products-litigation/

Prepared by the AllAboutLawyer.com Editorial Team and reviewed for factual accuracy against official MDL 3060 court records, the Verus LLC case management docket, and DiCello Levitt plaintiffs’ counsel filings on April 23, 2026. Last Updated: April 23, 2026

Disclaimer: This article is for informational purposes only and does not constitute legal advice. Legal claims and outcomes depend on specific facts and applicable law. For advice regarding a particular situation, consult a qualified attorney.